Debbie Etchison | Communications & IR |
Dr. Marco Taglietti | President & CEO |
Dr. David Angulo | Chief Medical Officer |
Ivor Macleod | Chief Financial Officer |
Louise Chen | Cantor |
Michael Higgins | Ladenburg Thalmann |
Shubhendu Sen Roy | Brookline Capital Markets |
Good morning, and welcome to the SCYNEXIS Third Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Debbie Etchison, Executive Director, Communications and Investor Relations.
Hello, everyone, and welcome to today's conference call to discuss our third quarter 2022 financial results and corporate update.
Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future, leadership's expectations for our future financial and operational performance, as well as our business strategy because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.